U.S. markets closed

PMV Pharmaceuticals, Inc. (PMVP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
36.43+2.32 (+6.80%)
At close: 4:00PM EDT
36.43 0.00 (0.00%)
After hours: 04:00PM EDT

PMV Pharmaceuticals, Inc.

8 Clarke Drive
Suite 3
Cranbury, NJ 08512
United States
609 642 6670

Full Time Employees44

Key Executives

NameTitlePayExercisedYear Born
Dr. David H. MackCo-Founder, CEO, Pres & Director770.33kN/A1962
Dr. Arnold J. Levine Ph.D.Co-Founder, Independent Director & Member of Scientific Advisory Board110kN/A1940
Mr. Winston KungCOO & CFO608.93kN/A1976
Dr. Leila AllandChief Medical Officer629.67kN/A1963
Dr. Thomas E. Shenk Ph.D.Co-Founder & Member of Scientific Advisory BoardN/AN/A1947
Mr. Robert TicktinGen. Counsel & Company Sec.N/AN/A1962
Dr. Deepika Jalota Pharm.D.Chief Regulatory & Quality Assurance OfficerN/AN/A1977
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores p53 function. It is also developing p53 R273H mutation and other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Corporate Governance

PMV Pharmaceuticals, Inc.’s ISS Governance QualityScore as of July 1, 2021 is 10. The pillar scores are Audit: 6; Board: 10; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.